Clinical research - Press Releases

Date	Title	Company
05-Mar-2022	Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022	SMi Group
28-Feb-2022	mdgroup to partner with ERGOMED on new Rare Disease Innovation Center	mdgroup
28-Feb-2022	ERGOMED announces launch of its Rare Disease Innovation Center™	ERGOMED
26-Feb-2022	STEMart Releases Subacute & Subchronic Toxicity Service for Medical Device Industry	STEMart
26-Feb-2022	CD Bioparticles Launches Ficolls to Support Bio-research	CD Bioparticles
23-Feb-2022	New Phase 2b Data Show the Majority of Adults with Moderately to Severely Active Ulcerative Colitis Achieved Clinical Response with TREMFYA®▼ (guselkumab) at 12 Weeks	Janssen
23-Feb-2022	Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab▼ and Golimumab Combination Therapy Versus Either Monotherapy Alone	Janssen
23-Feb-2022	The Majority of Adults with Moderately to Severely Active Crohn’s Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA®▼ (guselkumab)	Janssen
23-Feb-2022	PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning	PureTech
22-Feb-2022	Europe’s Only Parallel Trade Conference returns for its 16th Year	SMi Group
18-Feb-2022	Darolutamide shows significant increase in overall survival and decrease in disease progression in men with metastatic hormone-sensitive prostate cancer	Bayer
17-Feb-2022	SMART researchers discover unique lysin capable of killing deadly multidrug-resistant bacteria	Blue Totem Communications
15-Feb-2022	mdgroup Appoints Steph Katz as Director of Seacole Health	mdgroup
15-Feb-2022	Scientists uncover unique immune cell surveillance mechanism	Francis Crick Institute and King's College London
15-Feb-2022	Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2022	mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index	mdgroup
11-Feb-2022	Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children	Emmes
10-Feb-2022	InfanDx AG: Clinical Findings from Prospective AAMBI Study Highlight Need for Better Early Detection of Neonatal Brain Injury	InfanDx AG
09-Feb-2022	Book to attend the Parallel Trade conference before seats are filled	SMi Group
08-Feb-2022	Peripheral IV Catheters Being Used for Injecting Contrast Media during CT	P&S Intelligence